You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 22, Dec 12/26, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Quality of Care, Other
 •Bacterial Infections
 •Alert me on articles by topic

History Forgotten Is History Relived

Nosocomial Infection Control Is Also Essential in the Outpatient Setting

Arch Intern Med. 2005;165:2565-2567.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Those who cannot remember the past are condemned to repeat it.

George Santayana (1863-1952), The Life of Reason

One of the most important technologic advances in the history of medicine was the discovery in the last century that intravenous (IV) cannulation allows access to the bloodstream for administration of life-saving fluids, blood products, and drugs. In recent years, long-term vascular access with cuffed and tunneled Hickman-like central venous catheters (CVCs), subcutaneous central venous ports, and peripherally inserted central venous catheters (PICCs) has been sufficiently refined to permit stable access for months or even indefinitely for hemodialysis, parenteral nutrition, or cytotoxic cancer chemotherapy.

Unfortunately, vascular access is associated with underappreciated potential for producing iatrogenic bloodstream infection (BSI).1 There are 2 major sources of IV device (IVD)–related BSI2: (1) colonization of the IVD (catheter-related infection) and (2) contamination of the fluid administered through the device (infusate-related infection). . . . [Full Text of this Article]


AUTHOR INFORMATION
Dennis G. Maki, MD; Christopher J. Crnich, MD


RELATED ARTICLE

Outbreak of Catheter-Associated Klebsiella oxytoca and Enterobacter cloacae Bloodstream Infections in an Oncology Chemotherapy Center
John T. Watson, Roderick C. Jones, Alicia M. Siston, Julio R. Fernandez, Karen Martin, Elizabeth Beck, Steven Sokalski, Bette J. Jensen, Matthew J. Arduino, Arjun Srinivasan, and Susan I. Gerber
Arch Intern Med. 2005;165(22):2639-2643.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.